Global Information
회사소개 | 문의 | 위시리스트

일본의 양자선 치료 시장 : 암별 환자수, 상환 정책, 치료 환자수

Japan Proton Therapy Market, Patients by 10 Cancer Types(CNS, Head and Neck, Lung, GI, HCC, Pancreas, Gynecologic, Prostate, etc.), Reimbursement Policies & Persons Treated at Centers

리서치사 Renub Research
발행일 2019년 09월 상품 코드 427205
페이지 정보 영문 105 Pages
가격
US $ 1,995 ₩ 2,407,000 Unprintable PDF by E-mail (Single User License)
US $ 2,495 ₩ 3,011,000 PDF by E-mail (5 User License)
US $ 2,495 ₩ 3,011,000 Unprintable PDF and Hard Copy
US $ 2,995 ₩ 3,614,000 PDF by E-mail (Global Site License)

주의 : 본 보고서는 PDF 파일 이용 시 라이선스에 따라 보고서 인쇄가 제한됩니다.
Single User License 구입 시에는 인쇄가 불가능하므로 이용에 주의하시기 바랍니다.



일본의 양자선 치료 시장 : 암별 환자수, 상환 정책, 치료 환자수 Japan Proton Therapy Market, Patients by 10 Cancer Types(CNS, Head and Neck, Lung, GI, HCC, Pancreas, Gynecologic, Prostate, etc.), Reimbursement Policies & Persons Treated at Centers
발행일 : 2019년 09월 페이지 정보 : 영문 105 Pages

일본의 양자선 치료(Proton Therapy) 시장을 조사했으며, 실제 시장과 잠재 시장 규모 추정과 예측, 실제 환자수와 잠재 환자수 추정과 예측, 암별 시장 규모·환자수 추정과 예측, 상환 정책, 표준적인 양자선 치료센터의 설비, 주요 기업 분석, 시장 성장 촉진요인과 과제 분석 등을 정리했습니다.

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 추정과 예측

  • 실제 시장
  • 잠재 시장

제5장 환자수 추정과 예측

  • 실제 환자수
  • 잠재 환자수

제6장 환자수 추정과 예측 : 암 종류별

  • 중추신경계(CNS) 종양
  • 두경부암
  • 폐암
  • 소화기(GI)암
  • 간세포(HCC)암
  • 췌장암
  • 부인과 종양
  • 전립선암
  • 골종양 및 연부종양
  • 기타

제7장 시장 추정과 예측 : 암 종류별

  • 중추신경계(CNS) 종양
  • 두경부암
  • 폐암
  • 소화기(GI)암
  • 간세포(HCC)암
  • 췌장암
  • 부인과 종양
  • 전립선암
  • 골종양 및 연부종양
  • 기타

제8장 양자선 치료센터 리스트

  • 운용중
  • 건설중

제9장 치료중인 환자수 추정 : 센터별

  • Kashiwa (NCC) Proton Therapy Center
  • Hyogo (HIBMC) Proton Therapy Center
  • Tsukuba (PMRC, 2) Proton Therapy Center
  • WERC Proton Therapy Center
  • Shizuoka Proton Therapy Center
  • Koriyama-City Proton Therapy Center
  • Ibusuki (MMRI) Proton Therapy Center
  • Fukui City (Prefectural Hospital) Proton Therapy Center
  • Nagoya PTC, Nagoya, Aichi Proton Therapy Center
  • Tosu (Saga-HIMAT) Proton Therapy Center
  • Nagano Proton Therapy Center
  • Hokkaido Proton Therapy Center

제10장 상환 정책

제11장 표준적인 양자선 치료센터의 설비

  • 양성자 가속기
    • Synchrotrons(예 : LLUMC at Loma Linda)
    • Cyclotrons(예 : MGH Boston)
    • Synchrocyclotrons(예 : Orsay, Uppsala)
    • Linac(Rome)
    • H-minus Synchrotrons
    • Separated Sector Cyclotrons
    • Super-conducting Cyclotrons
    • Fast Cycling Synchrotron
  • 빔 수송 시스템
  • 빔 딜리버리 시스템
    • 수동 스캐터링 기술
    • 빔 스캐닝
  • 노즐
    • 싱글 스캐터링
    • 더블 스캐터링
    • 유니폼 스캐닝
    • 펜슬 스캐닝
  • 치료 플래닝 시스템
  • 영상 뷰어
  • 환자 포지셔닝 시스템(PPS)
  • 인적자원

제12장 기업 분석

  • IBA Proton Therapy
  • Varian Medical Systems
  • Elekta

제13장 양자선 치료 : 성장 촉진요인

  • 기술 진보
  • 일본의 암환자 발생률 증가

제14장 양자선 치료 : 과제

  • 대규모 투자 필요성
  • 운영상 과제
KSM 19.09.11

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

List of Figures

  • Figure 2-1: Japan - Proton Therapy Market (Million US$), 2009 - 2018
  • Figure 2-2: Japan - Forecast for Proton Therapy Market (Million US$), 2019 - 2025
  • Figure 2-3: Japan - Untapped Proton Therapy Market (Million US$), 2009 - 2018
  • Figure 2-4: Japan - Forecast for Untapped Proton Therapy Market (Million US$), 2019 - 2025
  • Figure 3-1: Japan - Patient Treated with Proton Therapy (Number), 2009 - 2018
  • Figure 3-2: Japan - Forecast for Patient Treated with Proton Therapy (Number), 2019 - 2025
  • Figure 3-3: Japan - Untapped Patients for Proton Therapy (Number), 2009 - 2018
  • Figure 3-4: Japan - Forecast for Untapped Patients for Proton Therapy (Number), 2019 - 2025
  • Figure 4-1: Japan - Proton Therapy Patients by CNS (Number), 2009 - 2018
  • Figure 4-2: Japan - Forecast for Proton Therapy Patients by CNS (Number), 2019 - 2025
  • Figure 4-3: Japan - Proton Therapy Patients by Head and Neck (Number), 2009 - 2018
  • Figure 4-4: Japan - Forecast for Proton Therapy Patients by Head and Neck (Number), 2019 - 2025
  • Figure 4-5: Japan - Proton Therapy Patients by Lung Cancer (Number), 2009 - 2018
  • Figure 4-6: Japan - Forecast for Proton Therapy Patients by Lung Cancer (Number), 2019 - 2025
  • Figure 4-7: Japan - Proton Therapy Patients by GI Cancer (Number), 2009 - 2018
  • Figure 4-8: Japan - Forecast for Proton Therapy Patients by GI Cancer (Number), 2019 - 2025
  • Figure 4-9: Japan - Proton Therapy Patients by HCC (Number), 2009 - 2018
  • Figure 4-10: Japan - Forecast for Proton Therapy Patients by HCC (Number), 2019 - 2025
  • Figure 4-11: Japan - Proton Therapy Patients by Pancreas (Number), 2009 - 2018
  • Figure 4-12: Japan - Forecast for Proton Therapy Patients by Pancreas (Number), 2019 - 2025
  • Figure 4-13: Japan - Proton Therapy Patients by Gynecologic Cancer (Number), 2009 - 2018
  • Figure 4-14: Japan - Forecast for Proton Therapy Patients by Gynecologic Cancer (Number), 2019 - 2025
  • Figure 4-15: Japan - Proton Therapy Patients by Prostate Cancer (Number), 2009 - 2018
  • Figure 4-16: Japan - Forecast for Proton Therapy Patients by Prostate Cancer (Number), 2019 - 2025
  • Figure 4-17: Japan - Proton Therapy Patients by Bone and Soft Tissue (Number), 2009 - 2018
  • Figure 4-18: Japan - Forecast for Proton Therapy Patients by Bone and Soft Tissue (Number), 2019 - 2025
  • Figure 4-19: Japan - Proton Therapy Patients by Others (Number), 2009 - 2018
  • Figure 4-20: Japan - Forecast for Proton Therapy Patients by Others (Number), 2019 - 2025
  • Figure 5-1: Japan - Proton Therapy Market by CNS (Million US$), 2009 - 2018
  • Figure 5-2: Japan - Forecast for Proton Therapy Market by CNS (Million US$), 2015 - 2025
  • Figure 5-3: Japan - Proton Therapy Market by Head and Neck Cancer (Million US$), 2009 - 2018
  • Figure 5-4: Japan - Forecast for Proton Therapy Market by Head and Neck Cancer (Million US$), 2019 - 2025
  • Figure 5-5: Japan - Proton Therapy Market by Lung Cancer (Million US$), 2009 - 2018
  • Figure 5-6: Japan - Forecast for Proton Therapy Market by Lung Cancer (Million US$), 2019 - 2025
  • Figure 5-7: Japan - Proton Therapy Market by GI Cancer (Million US$), 2009 - 2018
  • Figure 5-8: Japan - Forecast for Proton Therapy Market by GI Cancer (Million US$), 2019 - 2025
  • Figure 5-9: Japan - Proton Therapy Market by HCC (Million US$), 2009 - 2018
  • Figure 5-10: Japan - Forecast for Proton Therapy Market by HCC (Million US$), 2019 - 2025
  • Figure 5-11: Japan - Proton Therapy Market by Pancreas (Million US$), 2009 - 2018
  • Figure 5-12: Japan - Forecast for Proton Therapy Market by Pancreas (Million US$), 2019 - 2025
  • Figure 5-13: Japan - Proton Therapy Market by Gynecologic cancers (Million US$), 2009 - 2018
  • Figure 5-14: Japan - Forecast for Proton Therapy Market by Gynecologic cancers (Million US$), 2019 - 2025
  • Figure 5-15: Japan - Proton Therapy Market by Prostate cancers (Million US$), 2009 - 2018
  • Figure 5-16: Japan - Forecast for Proton Therapy Market by Prostate cancers (Million US$), 2019 - 2025
  • Figure 5-17: Japan - Proton Therapy Market by Bone and Soft Tissue (Million US$), 2009 - 2018
  • Figure 5-18: Japan - Forecast for Proton Therapy Market by Bone and Soft Tissue (Million US$), 2019 - 2025
  • Figure 5-19: Japan - Proton Therapy Market by Others (Million US$), 2009 - 2018
  • Figure 5-20: Japan - Forecast for Proton Therapy Market by Others (Million US$), 2019 - 2025
  • Figure 10-1: Global - IBA Proton Therapy Sales (Million USD), 2014 - 2018
  • Figure 10-2: Global - Forecast for IBA Proton Therapy Sales (Million USD), 2019 - 2025
  • Figure 10-3: Global - Varian Medical Systems Oncology Systems Sales (Million USD), 2014 - 2018
  • Figure 10-4: Global - Forecast for Varian Medical Systems Oncology Systems Sales (Million USD), 2019 - 2025
  • Figure 10-5: Global - Elekta Revenue, (Million USD), 2014 - 2018
  • Figure 10-6: Global - Forecast for Elekta Revenue (Million USD), 2019 - 2025
  • Figure 11-1: Japan - Number of Patient Diagnosed With Cancer (Thousand), 2014 - 2018
  • Figure 11-2: Japan - Forecast for Number of Patient Diagnosed With Cancer (Thousand), 2019 - 2025

List of Tables:

  • Table 6-1: Japan - Proton Therapy Centers in Operation
  • Table 6-2: Japan - Proton Therapy Centers in Under-Construction
  • Table 7-1: Japan - Kashiwa (NCC) Proton Therapy Center with Patients Treated (Number), 2008 - 2016
  • Table 7-2: Japan - Hyogo (HIBMC) Proton Therapy Center with Patients Treated (Number), 2008 - 2016
  • Table 7-3: Japan - Tsukuba (PMRC, 2) Proton Therapy Center with Patients Treated (Number), 2008 - 2016
  • Table 7-4: Japan - WERC Proton Therapy Center with Patients Treated (Number), 2008 - 2009
  • Table 7-5: Japan - Shizuoka Proton Therapy Center with Patients Treated (Number), 2008 - 2016
  • Table 7-6: Japan - Koriyama-City Proton Therapy Center with Patients Treated (Number), 2011 - 2016
  • Table 7-7: Japan - Ibusuki (MMRI) Proton Therapy Center with Patients Treated (Number), 2011 - 2016
  • Table 7-8: Japan - Fukui City (Prefectural Hospital) Proton Therapy Center with Patients Treated (Number), 2013 - 2015
  • Table 7-9: Japan - Nagoya PTC, Nagoya, Aichi Proton Therapy Center with Patients Treated (Number), 2013 - 2016
  • Table 7-10: Japan - Tosu (Saga-HIMAT) Proton Therapy Center with Patients Treated (Number), 2013
  • Table 7-11: Japan - Nagano Proton Therapy Center with Patients Treated (Number), 2014 - 2016

In Japan, the University of Tsukuba started clinical research and development in the year 1983. This was the first university in Japan that facilitates research and development of proton therapy and it created various milestones at various levels like started treatment of multiple cancerous tumors and creating a worldwide standard of proton therapy etc. In Japan, the number of patients eligibility for proton therapy is much higher than the proton therapy center, which treated the patients. According to our research, Japan is the largest proton therapy hub in Asia. The Japan Proton Therapy Market potential is expected to cross US$ 6 Billion by the end of the year 2025.

Rising cancer prevalence, increasing aging population, growing per capita expenditure, increasing number of proton therapy center in Japan will further boost the proton therapy market in the future course of time. In the early time, proton therapy was used to treat specific kind of cancers like prostate, CNS etc. but now proton therapy technology can treat various cancer at every stage of life; from pediatric to adult and old age also.

Patients Insight - Japan Proton Therapy

This report contains full information about patients, who are likely to get treated with proton therapy, the actual number of patients who have received proton therapy treatment. Moreover we have also categorized the patients on the basis of disease or cancer type into 10 parts; Head and Neck Cancer, Central Nervous System (CNS) Tumors, GI (Gastro-Intestinal) Cancer, Hepatocellular Carcinoma (HCC), Pancreas Cancer, Prostate Cancer, Lung Cancer, Gynecologic Cancers, Bone and Soft Tissue Cancer, Others). We have also provided an in-depth analysis of proton therapy center in Japan, providing a treated patient number by each year and by each operational center in Japan.

Market Insight - Japan Proton Therapy

Japan is one of the largest hubs of proton therapy center in the Asian region. The rising technological development and increasing cutting-edge technology in radiotherapy in Japan will further propel the proton therapy market of Japan in the forecast period. Currently, Japan has XXXX operational proton therapy center and XXXX new under-constructional phase proton therapy center project. The rising new under-contraction proton therapy center in Japan due to cancer patient in Japan is increasing at a rapid pace, and it will continue in the future course of time.

Renub Research report “Japan Proton Therapy Market, Patients by 10 Cancer Types (Central Nervous System (CNS), Head and Neck, Lung, GI (Gastro-Intestinal), Hepatocellular Carcinoma (HCC), Pancreas, Gynecologic, Prostate, Bone and Soft Tissue, Others) Reimbursement Policies & Persons Treated at Centers” provides a comprehensive assessment of the fast-evolving, high-growth of Japan Proton Therapy Market.

The report studies the market and patients numbers, of 10 individual cancer types who are treated under proton therapy. The report also talks about the list of all operational and future Proton Therapy centers; Reimbursement Policies. The report also studies the Proton Therapy Revenue of 3 Companies.

Types of Proton Therapy Market (Actual & Untapped)

  • 1. Actual Market is the current market which is already present.
  • 2. Untapped Market is the market which can be achieved, but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year.

Japan Proton Therapy Market has been analyzed from six viewpoints

  • 1. Actual Market
  • 2. Potential Market
  • 3. Treated Patient Numbers
  • 4. Untapped Patient Numbers
  • 5. Cancer Type - Japan Proton Therapy Market
  • 6. Cancer Type - Japan Proton Therapy Number of Patients

10 Types of Cancer Patient Numbers and Market in Japan Proton Therapy

  • 1. Central Nervous System (CNS) Tumors
  • 2. Head and Neck Cancer
  • 3. Prostate Cancer
  • 4. Lung Cancer
  • 5. GI (Gastro-Intestinal) Cancer
  • 6. Hepatocellular Carcinoma (HCC) Cancer
  • 7. Pancreas Cancer
  • 8. Gynecologic Cancers
  • 9. Bone and Soft Tissue Cancer
  • 10. Others Cancer

Key Companies Covered:

  • 1. IBA (Overview, Sales Analysis)
  • 2. Varian Medical Systems (Overview, Sales Analysis)
  • 3. Elekta (Overview, Sales Analysis)

Table of Contents

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market (Actual & Untapped) - Japan Proton Therapy (2009 - 2025)

  • 4.1. Actual Proton Therapy Market
  • 4.2. Untapped Proton Therapy Market

5. Number of Patients - Japan Proton Therapy (2009 - 2025)

  • 5.1. Actual Numbers
  • 5.2. Untapped Numbers

6. Cancer Types - Japan Proton Therapy Number of Patients (2009 - 2025)

  • 6.1. Central Nervous System (CNS) Tumors
  • 6.2. Head and Neck Cancer
  • 6.3. Lung Cancer
  • 6.4. GI (Gastro-Intestinal) Cancer
  • 6.5. Hepatocellular Carcinoma (HCC) Cancer
  • 6.6. Pancreas Cancer
  • 6.7. Gynecologic Cancers
  • 6.8. Prostate Cancer
  • 6.9. Bone and Soft Tissue Cancer
  • 6.10. Others Cancer

7. Cancer Types - Japan Proton Therapy Market (2009 - 2025)

  • 7.1. Central Nervous System (CNS) Tumors
  • 7.2. Head and Neck Cancer
  • 7.3. Lung Cancer
  • 7.4. GI (Gastro-Intestinal) Cancer
  • 7.5. Hepatocellular Carcinoma (HCC) Cancer
  • 7.6. Pancreas Cancer
  • 7.7. Gynecologic Cancers
  • 7.8. Prostate Cancer
  • 7.9. Bone and Soft Tissue Cancer
  • 7.10. Others Cancer

8. Japan - List of Proton Therapy Centers

  • 8.1. Operating Proton Therapy Centers
  • 8.2. Under-Construction Therapy Centers

9. By Centers - Number of Proton Therapy Patients Treated

  • 9.1. Kashiwa (NCC) Proton Therapy Center (2008 - 2016)
  • 9.2. Hyogo (HIBMC) Proton Therapy Center (2008 - 2016)
  • 9.3. Tsukuba (PMRC, 2) Proton Therapy Center (2008 - 2016)
  • 9.4. WERC Proton Therapy Center (2008 - 2009)
  • 9.5. Shizuoka Proton Therapy Center (2008 - 2016)
  • 9.6. Koriyama-City Proton Therapy Center (2008 - 2016)
  • 9.7. Ibusuki (MMRI) Proton Therapy Center (2011 - 2016)
  • 9.8. Fukui City (Prefectural Hospital) Proton Therapy Center (2013 - 2015)
  • 9.9. Nagoya PTC, Nagoya, Aichi Proton Therapy Center (2013 - 2016)
  • 9.10. Tosu (Saga-HIMAT) Proton Therapy Center (2013)
  • 9.11. Nagano Proton Therapy Center (2014 - 2016)
  • 9.12. Hokkaido Proton Therapy Center (2014 - 2016)

10. Reimbursement Policies - Japan Proton Therapy

11. Components of a Standard Proton Therapy Center

  • 11.1. Type of Proton Accelerator
    • 11.1.1. Synchrotrons (example: LLUMC at Loma Linda)
    • 11.1.2. Cyclotrons (example: MGH Boston)
    • 11.1.3. Synchrocyclotrons (examples: Orsay, Uppsala)
    • 11.1.4. Linacs (Rome)
    • 11.1.5. H-minus Synchrotrons
    • 11.1.6. Separated Sector Cyclotrons
    • 11.1.7. Super-conducting Cyclotrons
    • 11.1.8. Fast Cycling Synchrotron
  • 11.2. Beam Transport System
  • 11.3. Beam Delivery System
    • 11.3.1. The Passive Scattering Technique
    • 11.3.2. Beam Scanning
  • 11.4. Type of Nozzle
    • 11.4.1. Single Scattering
    • 11.4.2. Double Scattering
    • 11.4.3. Uniform Scanning Nozzle
    • 11.4.4. Pencil Scanning Nozzle
  • 11.5. Treatment Planning System
  • 11.6. Image Viewers
  • 11.7. Patient Positioning System (PPS)
  • 11.8. Human Resource

12. Company Analysis (2014 - 2025)

  • 12.1. IBA Proton Therapy
    • 12.1.1. Sales Analysis
  • 12.2. Varian Medical Systems
    • 12.2.1. Sales Analysis
  • 12.3. Elekta
    • 12.3.1. Sales Analysis

13. Proton Therapy - Driving Factors

  • 13.1. Technology Advancement
    • 13.1.1. Next-Generation Proton Technique
  • 13.2. Growing Incidence of Cancer Patients in Japan

14. Challenges

  • 14.1. Requires Huge Investment
  • 14.2. Operation Challenges
Back to Top
전화 문의
F A Q